2COOPMAN P J,DO M T,BARTH M,et al.The Syk tyrosine ki-nase suppresses malignant growth of human breast cancer cells[J].Nature,2000,406(6797):742-747.
3CARTER W B,NIU G,WARD M D,et al.Mechanisms of HER2-induced endothelial cell retraction[J].Ann Surg Oncol,2007,14(10):2971-2978.
4STONECYPHER M S,CHAUDHURY A R,BYER S J,et al.Neuregulin growth factors and their ErbB receptors form a potentialsignaling network for schwannoma tumorigenesis[J].NeuropatholExp Neurol,2006,65(2):162-175.
5ROCHALIMA C M,SOARES H P,RAEZ L E,et al.EGFR targe-ting of solid tumors[J].Cancer Control,2007,14(3):295-304.
6GALIZIA G,LIETO E,ORDITURA M,et al.Epidermal growthfactor receptor(EGFR)expression is associated with a worse prog-nosis in gastric cancer patients undergoing curative surgery[J].World J Surg,2007,31(7):1458-1468.
7LIETO E,FERRARACCIO F,ORDITURA M,et al.Expressionof vascular endothelial growth factor(VEGF)and epidermalgrowth factor receptor(EGFR)is an independent prognostic indi-cator of worse outcome in gastric cancer patients[J].Ann SurgOncol,2008,15(1):69-79.
8BONAVIDA B.Preface:antibody therapies for cancer[J].Onco-gene,2007,26(25):3592-3593.
9ZHANG X L,YANG Y S,XU D P,et al.Comparative study onoverexpression of HER2/neu and HER3 in gastric cancer[J].World J Surg,2009,33(10):2112-2118.
10PETRELLI N J,WINER E P,BRAHMER J,et al.Clinicalcancer advances 2009.Major research advances in cancer treat-ment,prevention,and screening.A report from the American So-ciety of Clinical Oncology[J].J Clin Oncol,2009,27(35):6052-6069.
